Demegestone
Progestin | |
ATC code | |
---|---|
Pharmacokinetic data | |
Bioavailability | Good[2] |
Metabolism | Hydroxylation, others[2] |
Metabolites | • 21-Hydroxydemegestone[2] • Others[2] |
Excretion | Urine[2] |
Identifiers | |
| |
JSmol) | |
| |
|
Demegestone, sold under the brand name Lutionex, is a
Demegestone is a progestin, or a
Demegestone was first described in 1966 and was introduced for medical use in France in 1974.[3][4] It has only been marketed in France, and has since been discontinued in this country.[5][4]
Medical uses
Demegestone has been used to treat
Side effects
Pharmacology
Pharmacodynamics
Demegestone is a
Compound | PR | AR | ER | GR | MR | SHBG | CBG
| |
---|---|---|---|---|---|---|---|---|
Demegestone | 230 | 1 | 0 | 5 | 1–2 | ? | ? | |
Notes: Values are percentages (%). Reference . Sources: |
Pharmacokinetics
Demegestone has good
Chemistry
Demegestone, also known as 17α-methyl-δ9-19-norprogesterone or as 17α-methyl-19-norpregna-4,9-diene-3,20-dione, is a
History
Demegestone was first described in the literature in 1964 and was introduced for medical use in 1974 in France.[3][4] It was developed by Roussel Uclaf.[4]
Society and culture
Generic names
Demegestone is the
.Brand names
Demegestone was marketed under the brand name Lutionex.[3][4]
Availability
Demegestone is no longer marketed and hence is no longer available in any country.[5] It was previously available in France.[5][4]
References
- ^ PMID 12158578.
- ^ ISSN 0022-4731.
- ^ ISBN 978-1-4757-2085-3.
- ^ ISBN 978-0-8155-1856-3.
- ^ a b c d "Demegestone". Micromedex.: [permanent dead link]
- ^ S2CID 24616324.
- ^ PMID 3194612.
- ^ PMID 926114.
- ^ Hamada H, Nagao H, Toyoda H, Hayashi H, Akihiro L, Kotaki S (1970). "[Clinical observation on oral contraceptive effect by R-2453 (Abstracts of Papers Presented at Showa 44 in the field of gynecology])". Japanese Journal of Obstetrics and Gynecology-Acta Obstetrica et Gynaecologica Japonica. 22 (7): 753.
- ^ Levrier M (January 1979). "Treatment of Ovarian Sterility with Combined Moxestrol-Demegestone Preparation". Journal de Gynécologie Obstétrique et Biologie de la Reproduction. 8 (1). Paris, France: Masson Editeur: 89.
- ^ Rabe T, Goeckenjan M, Ahrendt HJ, Crosignani PG, Dinger JC, Mueck AO, et al. (October 2011). "Oral Contraceptive Pills: Combinations, Dosages and the Rationale behind 50 Years or Oral Hormonal Contraceptive Development" (PDF). Journal für Reproduktionsmedizinund Endokrinologie. 8 (1): 58–129.
- ISBN 978-1-349-81347-6.
- ^ PMID 7382482.
- PMID 895725.
- PMID 7421203.
- S2CID 21336380.
- PMID 359134.